Overview

A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Fluoroquinolones
Gatifloxacin
Moxifloxacin
Ophthalmic Solutions